We sat down with J&J Innovation to see what it wants from potential life science partners.

Zealand Pharma has become the latest European biotech to file for a Nasdaq IPO.

Caribou has seen biopharma vet and former Arrowhead exec Steven Kanner join the biotech.

Sienna Pharmaceuticals is joining the growing biotech IPO renaissance this year as it goes for a $75 million offering.

Clementia Pharmaceuticals has filed to raise $115 million in an IPO.

Atlas Venture has raised its 11th fund, totaling $350 million.

Vivace Therapeutics has emerged from stealth with two funding rounds to the tune of $40 million.

LogicBio Therapeutics has got off a $45 million series B funding round.

It’s time again to call on you to nominate your Fierce 15 for 2017.

Venture Capital